表纸
市场调查报告书

全球干细胞市场预测(2021-2028)

Global Stem Cell Market Forecast 2021-2028

出版商 Inkwood Research 商品编码 969281
出版日期 内容资讯 英文 310 Pages
商品交期: 2-3个工作天内
价格
全球干细胞市场预测(2021-2028) Global Stem Cell Market Forecast 2021-2028
出版日期: 2020年11月09日内容资讯: 英文 310 Pages
简介

在预测期内2021-2028年,全球干细胞市场预计将以7.82%的复合年增长率增长。推动市场增长的关键因素包括:再生医学对干细胞的需求增加,对脐带干细胞的认识提高,对干细胞治疗和研究的研发投资激增以及技术进步。

干细胞具有惊人的潜力,因为副分泌促进伤口修复和皮肤组织再生。目前,作为间质干细胞,许多细胞类型,胚胎干细胞,上皮干细胞,驻留组织干细胞,造血干细胞和脂肪来源的干细胞正在被广泛研究,并且可能有助于市场的显著增长。

该报告调查了全球干细胞市场,包括市场规模和估计,增长和限制因素,COVID-19的影响以及按治疗用途/产品/技术/用途/治疗类型/地区进行的市场分析,竞争状况,主要公司的概况等

目录

第1章调查范围和调查方法

  • 调查目的
  • 调查范围
  • 调查方法
  • 先决条件和限制

第2章执行摘要

  • 市场规模/估计
  • 市场概况

第3章市场动态

  • 主要增长因素
    • 再生医学对干细胞的需求迅速增加
    • 扩大干细胞疗法和研发投资
    • 提高对脐带血干细胞的认识
    • 减少植入物中组织排斥的风险
    • 技术进步
  • 主要制约因素
    • 严格的政府法规
    • 与干细胞疗法相关的高成本
    • 与干细胞有关的伦理问题和社会复杂性
    • 发达国家的响应能力下降

第4章主要分析

  • 波特的五力分析
  • COVID-19对干细胞市场的影响
  • 价值链分析
  • 主要购买标准
  • 干细胞的历史
  • 监管框架
  • 机会矩阵
  • 供应商状况
  • 主要投资见解

第五章按治疗应用划分的市场

  • 骨科治疗
  • 伤害和伤口
  • 肿瘤疾病
  • 心血管疾病
  • 神经系统疾病
  • 糖尿病
  • 其他治疗用途

第6章按产品划分的市场

  • 成年干细胞
    • 造血干细胞
    • 神经干
    • 脐带干细胞
    • 膜干细胞
    • 牙科干细胞
  • 人类胚胎干细胞
  • 多才多艺
  • 小鼠/大鼠神经元

第7章按技术划分的市场

  • 集合
    • 干细胞骨髓
    • 干细胞转移
    • 干细胞脐带
  • 冷冻保存
  • 扩张与亚文化
  • 制造业
    • 干细胞培养
    • 治疗性克隆
    • 试管婴儿

第8章按用途划分的市场

  • 再生医学
  • 药物发现与开发

第9章按治疗类型划分的市场

  • 同种异体干细胞疗法
  • 自动干细胞疗法
  • 同义词干细胞疗法

第10章区域分析

  • 北美
    • 市场规模/估计
    • 主要增长动力
    • 主要问题
    • 主要公司
    • 国家分析
  • 欧洲
  • 亚太地区
  • 其他地区

第11章竞争情况

  • 主要战略发展
    • 并购
    • 产品发布和开发
    • 联盟,合同与合作
    • 业务扩展/批准/公告
  • 公司简介
    • ALLCELLS LLC
    • BECTON, DICKINSON AND COMPANY (BD)
    • CORNING INC
    • CYTORI THERAPEUTICS
    • GE HEALTHCARE
    • INTERNATIONAL STEM CELL CORP
    • MERCK KGAA (SIGMA ALDRICH)
    • MILTENYI BIOTEC
    • PLURISTEM THERAPEUTICS INC
    • QIAGEN NV
    • SMITH & NEPHEW PLC
    • STEMCELL TECHNOLOGIES
    • STRYKER CORPORATION
    • TAKARA HOLDINGS INC
    • THERMO FISHER SCIENTIFIC INC
目录
Product Code: 4685

KEY FINDINGS

The global stem cell market is evaluated to grow with a CAGR of 7.82%, during the forecast period of 2021 to 2028. Primary factors driving the market growth include the rising demand for stem cells in regenerative medicine, growing awareness about umbilical cord stem cells, surging research and development investments in stem cell therapies and research, and technological advancements.

MARKET INSIGHTS

Stem cells possess remarkable potential, in terms of promoting wound repaid in a paracrine manner and cutaneous tissue regeneration. As mesenchymal stem cells, numerous cell types, embryonic stem cells, epithelial stem cells, resident tissue stem cells, hematopoietic stem cells, and adipose-derived stem cells are presently under extensive investigation. As a result, this is likely to contribute to the significant growth of the stem cell market.

Umbilical cord stem cells as a non-invasive and efficacious alternative source of hematopoietic stem cells are gaining added awareness and prevalence. They are primarily utilized for treating a varied range of blood-, metabolic-, bone-, and immune system-related disorders and diseases. Moreover, the knowledge regarding the importance of the umbilical cord, as well as its applications, especially across developed markets, is steadily increasing.

REGIONAL INSIGHTS

The global stem cell market growth analysis includes the Asia Pacific, Europe, North America, and the rest of the world. The Asia Pacific observes an increased incidence of chronic diseases, such as cancer, in addition to growing medical tourism in developing nations like India and China, as well as improved economic stability. As a result, the region is anticipated to be the fastest-growing market for stem cells.

COMPETITIVE INSIGHTS

Since stem cells play a crucial role in toxicology studies and drug discovery, the intensity towards optimizing the technical strength for stem cells is continually growing. This factor is also crucial in bolstering the growth of the companies operating in the market. Hence, the degree of competitive rivalry is anticipated to increase further, and remain high, over the forecast period. The market's key players include, Corning Inc, Becton, Dickinson and Company (BD), GE Healthcare, Smith & Nephew PLC, Qiagen NV, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
    • 3.1.2. GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
    • 3.1.3. RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
    • 3.1.4. REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 3.2.2. HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
    • 3.2.3. ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
    • 3.2.4. LESS RESPONSIVENESS IN DEVELOPED ECONOMIES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON STEM CELL MARKET
  • 4.3. VALUE CHAIN ANALYSIS
  • 4.4. KEY BUYING CRITERIA
  • 4.5. HISTORY OF STEM CELL
  • 4.6. REGULATORY FRAMEWORK
  • 4.7. OPPORTUNITY MATRIX
  • 4.8. VENDOR LANDSCAPE
  • 4.9. KEY INVESTMENT INSIGHTS

5. MARKET BY THERAPEUTIC APPLICATION

  • 5.1. ORTHOPEDIC TREATMENTS
  • 5.2. INJURIES AND WOUNDS
  • 5.3. ONCOLOGY DISORDERS
  • 5.4. CARDIOVASCULAR DISORDERS
  • 5.5. NEUROLOGICAL DISORDERS
  • 5.6. DIABETES
  • 5.7. OTHER THERAPEUTIC APPLICATIONS

6. MARKET BY PRODUCT

  • 6.1. ADULT STEM CELL
    • 6.1.1. HEMATOPOIETIC STEM CELL
    • 6.1.2. NEURAL STEM
    • 6.1.3. UMBILICAL CORD STEM CELL
    • 6.1.4. MESENCHYMAL STEM CELL
    • 6.1.5. DENTAL STEM CELL
  • 6.2. HUMAN EMBRYONIC STEM CELL
  • 6.3. PLURIPOTENT
  • 6.4. MOUSE/RAT NEURAL

7. MARKET BY TECHNOLOGY

  • 7.1. ACQUISITION
    • 7.1.1. STEM CELL BONE MARROW MARKET
    • 7.1.2. STEM CELL APHERESIS
    • 7.1.3. STEM CELL UMBILICAL CORD
  • 7.2. CRYOPRESERVATION
  • 7.3. EXPANSION AND SUB-CULTURE
  • 7.4. PRODUCTION
    • 7.4.1. STEM CELL CULTURE
    • 7.4.2. THERAPEUTIC CLONING
    • 7.4.3. IVF

8. MARKET BY APPLICATION

  • 8.1. REGENERATIVE MEDICINE
  • 8.2. DRUG DISCOVERY AND DEVELOPMENT

9. MARKET BY TREATMENT TYPE

  • 9.1. ALLOGENEIC STEM CELL THERAPY
  • 9.2. AUTOLOGIC STEM CELL THERAPY
  • 9.3. SYNGENEIC STEM CELL THERAPY

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. MARKET SIZE & ESTIMATES
    • 10.2.2. KEY GROWTH ENABLERS
    • 10.2.3. KEY CHALLENGES
    • 10.2.4. KEY PLAYERS
    • 10.2.5. COUNTRY ANALYSIS
      • 10.2.5.1. GERMANY
      • 10.2.5.2. FRANCE
      • 10.2.5.3. UNITED KINGDOM
      • 10.2.5.4. ITALY
      • 10.2.5.5. RUSSIA
      • 10.2.5.6. BELGIUM
      • 10.2.5.7. POLAND
      • 10.2.5.8. REST OF EUROPE
  • 10.3. ASIA PACIFIC
    • 10.3.1. MARKET SIZE & ESTIMATES
    • 10.3.2. KEY GROWTH ENABLERS
    • 10.3.3. KEY CHALLENGES
    • 10.3.4. KEY PLAYERS
    • 10.3.5. COUNTRY ANALYSIS
      • 10.3.5.1. CHINA
      • 10.3.5.2. JAPAN
      • 10.3.5.3. INDIA
      • 10.3.5.4. AUSTRALIA & NEW ZEALAND
      • 10.3.5.5. SOUTH KOREA
      • 10.3.5.6. THAILAND
      • 10.3.5.7. INDONESIA
      • 10.3.5.8. VIETNAM
      • 10.3.5.9. REST OF ASIA PACIFIC
  • 10.4. REST OF WORLD
    • 10.4.1. MARKET SIZE & ESTIMATES
    • 10.4.2. KEY GROWTH ENABLERS
    • 10.4.3. KEY CHALLENGES
    • 10.4.4. KEY PLAYERS
    • 10.4.5. REGIONAL ANALYSIS
      • 10.4.5.1. LATIN AMERICA
      • 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGER & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 11.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 11.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 11.2. COMPANY PROFILE
    • 11.2.1. ALLCELLS LLC
    • 11.2.2. BECTON, DICKINSON AND COMPANY (BD)
    • 11.2.3. CORNING INC
    • 11.2.4. CYTORI THERAPEUTICS
    • 11.2.5. GE HEALTHCARE
    • 11.2.6. INTERNATIONAL STEM CELL CORP
    • 11.2.7. MERCK KGAA (SIGMA ALDRICH)
    • 11.2.8. MILTENYI BIOTEC
    • 11.2.9. PLURISTEM THERAPEUTICS INC
    • 11.2.10. QIAGEN NV
    • 11.2.11. SMITH & NEPHEW PLC
    • 11.2.12. STEMCELL TECHNOLOGIES
    • 11.2.13. STRYKER CORPORATION
    • 11.2.14. TAKARA HOLDINGS INC
    • 11.2.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - STEM CELL
  • TABLE 2: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ADULT STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL ADULT STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL NEURAL STEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL NEURAL STEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL DENTAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL DENTAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL PLURIPOTENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL PLURIPOTENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL ACQUISITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL ACQUISITION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 49: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 51: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL CRYOPRESERVATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 53: GLOBAL CRYOPRESERVATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 55: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 57: GLOBAL PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 59: GLOBAL PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL STEM CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 61: GLOBAL STEM CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 62: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 63: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 64: GLOBAL IVF MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 65: GLOBAL IVF MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 66: GLOBAL STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 67: GLOBAL STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 68: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 69: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 70: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 71: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 72: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 73: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 74: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 75: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 76: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 77: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 78: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 79: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 80: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 81: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 82: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 83: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 84: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET
  • TABLE 85: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 86: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 87: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET
  • TABLE 88: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 89: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 90: LEADING PLAYERS OPERATING IN ASIA PACIFIC STEM CELL MARKET
  • TABLE 91: REST OF WORLD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 92: REST OF WORLD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 93: LEADING PLAYERS OPERATING IN REST OF WORLD STEM CELL MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020
  • FIGURE 6: GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL STEM CELL MARKET, BY PRODUCT, IN 2020
  • FIGURE 14: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 24: GLOBAL STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL STEM CELL MARKET, BY APPLICATION, IN 2020
  • FIGURE 35: GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, IN 2020
  • FIGURE 38: GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 40: GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
  • FIGURE 41: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 42: UNITED STATES STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: CANADA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 45: GERMANY STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: FRANCE STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: UNITED KINGDOM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: ITALY STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: RUSSIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: BELGIUM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: POLAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: REST OF EUROPE STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: ASIA PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 54: CHINA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 55: JAPAN STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 56: INDIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 57: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 58: SOUTH KOREA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 59: THAILAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 60: INDONESIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 61: VIETNAM STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 62: REST OF ASIA PACIFIC STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 63: REST OF WORLD STEM CELL MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 64: LATIN AMERICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 65: MIDDLE EAST & AFRICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)